Related references
Note: Only part of the references are listed.Dose-Finding Study of a CEA-Targeting Agent, SGM-101, for Intraoperative Fluorescence Imaging of Colorectal Cancer
Kim S. de Valk et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety
Wendy Bernhard et al.
BMC CANCER (2021)
HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma
Patrick Sven Plum et al.
BMC CANCER (2019)
Efficacy of Assessing Intraoperative Bowel Perfusion with Near-Infrared Camera in Laparoscopic Gastric Cancer Surgery
Yeon-Ju Huh et al.
JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES (2019)
Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma
Stan van Keulen et al.
ORAL ONCOLOGY (2019)
Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach
JOURNAL OF GASTRIC CANCER (2019)
Clinical Significance of Glycoprotein Non-metastatic B and Its Association with EGFR/HER2 in Gastrointestinal Cancer
Jesse Yu Tajima et al.
JOURNAL OF CANCER (2018)
Association of HER2 gene amplification and tumor progression in early gastric cancer
Kazuki Kanayama et al.
VIRCHOWS ARCHIV (2018)
Superselective intra-arterial hepatic injection of indocyanine green (ICG) for fluorescence image-guided segmental positive staining: experimental proof of the concept
Michele Diana et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2017)
Activating HER2 mutations as emerging targets in multiple solid cancers
Claire M. Connell et al.
ESMO OPEN (2017)
Evaluation of the novel near-infrared fluorescence tracers pullulan polymer nanogel and indocyanine green/gamma-glutamic acid complex for sentinel lymph node navigation surgery in large animal models
Seong-Ho Kong et al.
GASTRIC CANCER (2015)
HER2 Expression in Gastric and Gastroesophageal Cancer: Report from a Tertiary Care Hospital in North India
Mallika Tewari et al.
INDIAN JOURNAL OF SURGERY (2015)
Near-Infrared Emitting Polymer Nanogels for Efficient Sentinel Lymph Node Mapping
Young-Woock Noh et al.
ACS NANO (2012)
Phage display peptide probes for imaging early response to bevacizumab treatment
Qizhen Cao et al.
AMINO ACIDS (2011)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
C. Gravalos et al.
ANNALS OF ONCOLOGY (2008)
The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines
Jin Won Kim et al.
CANCER LETTERS (2008)
Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging
Sang Bong Lee et al.
CLINICAL CANCER RESEARCH (2008)
99mTc-maEEE-ZHER2:342, an affibody molecule-based tracer for the detection of HER2 expression in malignant tumors
Thuy Tran et al.
BIOCONJUGATE CHEMISTRY (2007)
Share Paper
